<産業資料/調査レポートの題名> 2022年6月19日

グルコサミンの世界市場予測・分析2020-2024


◆英文タイトル:Glucosamine Market by Application and Geography - Forecast and Analysis 2020-2024

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY APPLICATION
• Market segmentation by application
• Comparison by application
• Arthritis – Market size and forecast 2019-2024
• Other applications – Market size and forecast 2019-2024
• Market opportunity by application
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Growing use of nutraceuticals in treating chronic diseases
• Shift toward production of glucosamine from vegetarian sources
• Increasing research funding in the field of nutraceuticals
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Blackmores Ltd.
• Cargill Inc.
• Ethical Naturals Inc.
• GNC Holdings Inc.
• Herbs Nutriproducts Pvt. Ltd.
• Jyorana International Pvt. Ltd.
• Natures Aid Ltd.
• NOW Health Group Inc.
• Pharma Nord Aps
• WynnPharm Inc.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO


Exhibit 01: Key offerings
Exhibit 02: Global pharmaceuticals market
Exhibit 03: Segments of global pharmaceuticals market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Application – Market share 2019-2024 (%)
Exhibit 19: Comparison by application
Exhibit 20: Arthritis – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: % Prevalence of arthritis by age in the US in 2013-15
Exhibit 22: Arthritis – Year-over-year growth 2020-2024 (%)
Exhibit 23: Other applications – Market size and forecast 2019-2024 ($ millions)
Exhibit 24: Other applications – Year-over-year growth 2020-2024 (%)
Exhibit 25: Market opportunity by application
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2019-2024 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 30: North America – Year-over-year growth 2020-2024 (%)
Exhibit 31: Top 3 countries in North America
Exhibit 32: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 34: Top 3 countries in Europe
Exhibit 35: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 36: Proportion of geriatric population in Asia 2009 and 2018 (% of the total population)
Exhibit 37: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 38: Top 3 countries in Asia
Exhibit 39: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 40: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 41: Top 3 countries in ROW
Exhibit 42: Key leading countries
Exhibit 43: Market opportunity
Exhibit 44: Growth of geriatric population 2009-2018 (%)
Exhibit 45: Alternative therapies for treating orthopedic conditions
Exhibit 46: Impact of drivers and challenges
Exhibit 47: Vendor landscape
Exhibit 48: Landscape disruption
Exhibit 49: Vendors covered
Exhibit 50: Vendor classification
Exhibit 51: Market positioning of vendors
Exhibit 52: Blackmores Ltd. – Vendor overview
Exhibit 53: Blackmores Ltd. – Business segments
Exhibit 54: Blackmores Ltd. – Organizational developments
Exhibit 55: Blackmores Ltd. – Segment focus
Exhibit 56: Blackmores Ltd. – Key offerings
Exhibit 57: Cargill Inc. – Vendor overview
Exhibit 58: Cargill Inc. – Business segments
Exhibit 59: Cargill Inc. – Organizational developments
Exhibit 60: Cargill Inc. – Geographic focus
Exhibit 61: Cargill Inc. – Key offerings
Exhibit 62: Ethical Naturals Inc. – Vendor overview
Exhibit 63: Ethical Naturals Inc. – Business segments
Exhibit 64: Ethical Naturals Inc. – Key offerings
Exhibit 65: GNC Holdings Inc. – Vendor overview
Exhibit 66: GNC Holdings Inc. – Business segments
Exhibit 67: GNC Holdings Inc. – Geographic focus
Exhibit 68: GNC Holdings Inc. – Segment focus
Exhibit 69: GNC Holdings Inc. – Key offerings
Exhibit 70: Herbs Nutriproducts Pvt. Ltd. – Vendor overview
Exhibit 71: Herbs Nutriproducts Pvt. Ltd. – Product segments
Exhibit 72: Herbs Nutriproducts Pvt. Ltd. – Key offerings
Exhibit 73: Jyorana International Pvt. Ltd. – Vendor overview
Exhibit 74: Jyorana International Pvt. Ltd. – Business segments
Exhibit 75: Jyorana International Pvt. Ltd. – Key offerings
Exhibit 76: Natures Aid Ltd. – Vendor overview
Exhibit 77: Natures Aid Ltd. – Product segments
Exhibit 78: Natures Aid Ltd. – Key offerings
Exhibit 79: NOW Health Group Inc. – Vendor overview
Exhibit 80: NOW Health Group Inc. – Product segments
Exhibit 81: NOW Health Group Inc. – Organizational developments
Exhibit 82: NOW Health Group Inc. – Key offerings
Exhibit 83: Pharma Nord Aps – Vendor overview
Exhibit 84: Pharma Nord Aps – Business segments
Exhibit 85: Pharma Nord Aps – Key offerings
Exhibit 86: WynnPharm Inc. – Vendor overview
Exhibit 87: WynnPharm Inc. – Product segments
Exhibit 88: WynnPharm Inc. – Key offerings
Exhibit 89: Validation techniques employed for market sizing
Exhibit 90: Definition of market positioning of vendors


LINEで送る
Share on LinkedIn
このエントリーをはてなブックマークに追加
Bookmark this on BuzzURL
Bookmark this on Yahoo Bookmark